DONNELLY HOWARD W 4

What Happened Howard W. Donnelly, a director of AngioDynamics, Inc. (ANGO), was granted 11,887 restricted stock units (RSUs) on July 15, 2026. The Form 4 reports the acquisition with a per-share price of $0.00 (code A — award/grant); the RSUs vested immediately at grant per the filing footnote. This was a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: July 15, 2026; Form 4 filed July 22, 2026 (appears to be filed after the transaction date).
• Reported transaction: 11,887 RSUs granted, acquisition price reported as $0.00 (award/grant).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: The 11,887 shares represent regular annual director compensation in the form of RSUs and vested immediately at grant.
• Filing timeliness: The Form 4 was filed seven days after the transaction date; this may reflect an administrative delay.

Context RSU grants to directors are common as routine compensation and do not necessarily signal the insider buying or selling stock. Acquisition code A and a $0.00 price simply reflect that these were awarded shares (restricted stock units) rather than a cash purchase. Because the RSUs vested immediately, Donnelly effectively received the shares upon grant under the terms noted in the filing.